Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Vaccine|January 10, 2012
Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signalingEvandro R Winkelmann, Douglas G Widman, Jingya Xia, et al.
The Journal of Antibiotics|December 13, 2022
Isolation, structural determination, and antiviral activities of metabolites from vanitaracin A-producing Talaromyces spShinji Kamisuki, Hisanobu Shibasaki, Hironobu Murakami, et al.
Molecules (Basel, Switzerland)|May 14, 2025
An Electron Paramagnetic Resonance Study of the Superoxide-Scavenging and Redox-Modulating Effects of Lecithinized Superoxide Dismutase in the BloodstreamDessislava Lazarova, Plamen Getsov, Rumiana Bakalova, et al.
The Prostate|September 11, 2020
The clinical benefit of sequential therapy with androgen receptor axis-targeted agents alone in patients with castration-resistant prostate cancer: A propensity score-matched comparison studyYushi Naito, Masashi Kato, Hideji Kawanishi, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of Selective Transforming Growth Factor β Type II Receptor Inhibitors as Antifibrosis AgentsShohei Miwa, Masahiro Yokota, Yoshifumi Ueyama, et al.
Vaccine|September 21, 2010
Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sowsJun-ichi Imoto, Tomohiro Ishikawa, Atsushi Yamanaka, et al.
The Journal of Antibiotics|May 30, 2024
Isolation, structural determination, and antiviral activities of a novel alanine-conjugated polyketide from Talaromyces spNozomi Mosu, Mitsuki Yasukochi, Shogo Nakajima, et al.
Emerging Microbes & Infections|May 29, 2024
Characterization of genotype V Japanese encephalitis virus isolates from Republic of KoreaAh-Ra Lee, Sang-Hyun Kim, Su-Yeon Hong, et al.
Biochemistry and Biophysics Reports|July 20, 2018
Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251Youki Ueda, Weilin Gu, Hiromichi Dansako, et al.
The American Journal of Tropical Medicine and Hygiene|June 4, 2010
Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infectionDouglas G Widman, Tomohiro Ishikawa, Luis D Giavedoni, et al.
Pageof 8